CivaTech
Share
CivaTech Oncology® designs innovative products that bring meaningful improvements to low dose rate brachytherapy.
08/31/2021
Cancer Experts Report Initial Findings of CivaSheet® Soft Tissue Sarcoma Registry Physicians from four medical centers recently published data this month from an initial six patients implanted with CivaSheet® to treat retroperitonea
11/11/2020
CivaTech Oncology, Inc. is advancing treatment with our uni-directional CivaSheet. CivaSheet has 100% local control for resectable patients implanted at the time of surgery. We are proud to be spotlighted in this tribute to Alex Trebek and hope his death will bring awareness to this disease.
Alex Trebek's death shines light on pancreatic cancer research being done in Triangle to enhance treatment Alex Trebek's death 18 months after a pancreatic cancer diagnosis comes as Triangle companies continue research on enhancing treatment of the disease.
10/27/2020
CivaTech Oncology and NYU Langone Health Launch NIH-sponsored Trial to Fight Lung Cancer Physicians from NYU Langone Health and its Perlmutter Cancer Center successfully treated their first patient in an NIH/NCI- sponsored clinical trial u
04/14/2020
CivaSheet featured in the news! Physicians at Fox Chase Cancer Center describe how the targeted, unidirectional CivaSheet can be used to easily provide treatments to patients who may not be eligible for other therapies.
CivaSheet offers doctors a new weapon in cancer fight It's a thin, flexible silicone sheet with tiny radiation dots embedded into it and it gives patients a new chance for radiation when cancer strikes again.
08/08/2018
CivaTech Oncology, Inc. Offers New Technology to Fight Lung Cancer CivaSheet is used to treat lung cancer by team at MSK Cancer Center. 2.3M of fast track funding from NIH/NCI is in place for a clinical trial.
05/23/2017
Radio segment on how the new CivaSheet® can enhance treatment for patients with pancreatic cancer, by WCVE - an NPR news station. Make sure to click play!
http://ideastations.org/radio/news/vcu-massey-cancer-center-first-nation-new-treatment-pancreatic-cancer
VCU Massey Cancer Center First in the Nation With New Treatment For Pancreatic Cancer The VCU Massey Cancer Center has become the first in the world to successfully implant a bio-absorbable implanted radiation device to treat the early stages of pancreatic cancer. Pancreatic cancer kills four out of five people diagnosed with the disease. Seventy-year old W***y Grubbs was on vacation...
CivaTech Oncology Press Release - Pancreatic Cancer
http://www.businesswire.com/news/home/20170523005909/en/CivaTech-Oncology-%C2%AE-Offers-Technology-Fight-Pancreatic
CivaTech Oncology Inc. ® Offers New Technology to Fight Pancreatic Cancer Physicians at VCU Massey Cancer Center in Richmond, VA are first in the world to implant a new bio-absorbable, unidirectional radiation treatment know
11/29/2016
Prostate Cancer & CivaString® - New FDA cleared Radiation Therapy A patient recounts his experience with CivaString® polymer encapsulated palladium radiation therapy for prostate cancer. Replaces traditional metal seeds wit...
11/15/2016
CivaTech Oncology Inc. Awarded Up To $2.3M from NIH for Pancreatic Cancer Study with CivaSheet® Device | Business Wire CivaTech Oncology Inc. has been awarded a fast-track NIH grant to treat pancreatic cancer patients with its new CivaSheet device. Patients will be tre
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
627 Davis Drive
Morrisville, NC
27560
Opening Hours
| Monday | 9:30am - 5:30pm |
| Tuesday | 9:30am - 5:30pm |
| Wednesday | 9:30am - 5:30pm |
| Thursday | 9:30am - 5:30pm |
| Friday | 9:30am - 5:30pm |